Inventor
SCHRAMM VERN L
US47 patents
⚠️ This page may combine multiple inventors who share the name “SCHRAMM VERN L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
EINSTEIN COLL MED
24 patentsUS5985848ANov 16, 1999
Inhibitors of nucleoside metabolism
EINSTEIN COLL MED94 citations99
US6066722AMay 23, 2000
Inhibitors of nucleoside metabolism
EINSTEIN COLL MED80 citations97
US7390890B2Jun 24, 2008
Inhibitors of nucleoside metabolism
EINSTEIN COLL MED46 citations96
US7211677B2May 1, 2007
Process for preparing inhibitors of nucleoside metabolism
EINSTEIN COLL MED31 citations96
US6803455B2Oct 12, 2004
Inhibitors of nucleoside metabolism
EINSTEIN COLL MED60 citations96
US6492347B2Dec 10, 2002
Inhibitors of nucleoside metabolism
EINSTEIN COLL MED61 citations96
US6228847B1May 8, 2001
Inhibitors of nucleoside metabolism
EINSTEIN COLL MED62 citations96
US7109331B2Sep 19, 2006
5H-pyrrolo[3,2-d]pyrimidine nucleoside metabolism inhibitors
EINSTEIN COLL MED37 citations92
US7098334B2Aug 29, 2006
4-amino-5H-pyrrolo[3,2-d]pyrimidine inhibitors of nucleoside phosphorylases and nucleosidases
EINSTEIN COLL MED40 citations92
US7022852B2Apr 4, 2006
Process for preparing inhibitors of nucleoside metabolism
EINSTEIN COLL MED31 citations92
US6764829B2Jul 20, 2004
Nucleoside hydrolase and nucleoside phosphorylase detection kits, dipsticks and substrates
EINSTEIN COLL MED30 citations92
US6379911B2Apr 30, 2002
Enzyme detection/assay method and substrates
EINSTEIN COLL MED28 citations92
US6895396B2May 17, 2005
Neural network methods to predict enzyme inhibitor or receptor ligand potency
EINSTEIN COLL MED26 citations91
US6678618B1Jan 13, 2004
Neural network methods to predict enzyme inhibitor or receptor ligand potency
EINSTEIN COLL MED23 citations91
US6185548B1Feb 6, 2001
Neural network methods to predict enzyme inhibitor or receptor ligand potency
EINSTEIN COLL MED40 citations91
US6121296ASep 19, 2000
Transition-state inhibitors for nucleoside hydrolase and transferase reactions
EINSTEIN COLL MED30 citations87
US7777025B2Aug 17, 2010
Transition state analog inhibitors of ricin A-chain
EINSTEIN COLL MED11 citations84
US7022680B2Apr 4, 2006
Inhibitors of ADP-ribosyl transferases, cyclases, and hydrolases
EINSTEIN COLL MED16 citations84
US7504489B2Mar 17, 2009
Inhibitors of ADP-ribosyl transferases, cyclases, and hydrolases, and uses thereof
EINSTEIN COLL MED6 citations73
US7056894B2Jun 6, 2006
Inhibitors of ADP-ribosyl transferases, cyclases, and hydrolases, and uses thereof
EINSTEIN COLL MED9 citations73
US7741295B2Jun 22, 2010
Sir2 products and activities
EINSTEIN COLL MED5 citations72
US7432246B2Oct 7, 2008
Sir2 products and activities
EINSTEIN COLL MED6 citations72
US6987091B2Jan 17, 2006
Sir2 products and activities
EINSTEIN COLL MED9 citations72
US8383653B2Feb 26, 2013
SIR2 regulation
EINSTEIN COLL MED2 citations62
SCHRAMM VERN L
6 patentsUS8541567B2Sep 24, 2013
Transition state structure of 5′-methylthioadenosine/s-adenosylhomocysteine nucleosidases
SCHRAMM VERN L5 citations72
US9290501B2Mar 22, 2016
Methods, assays and compounds for treating bacterial infections by inhibiting methylthioinosine phosphorylase
SCHRAMM VERN L3 citations71
US8536319B2Sep 17, 2013
Compounds and methods for detecting ricin and uses thereof
SCHRAMM VERN L2 citations59
US8835467B2Sep 16, 2014
SIR2 regulation
SCHRAMM VERN L1 citations51
US8916571B2Dec 23, 2014
Methods of treating cancer using inhibitors of 5′-methylthioadenosine phosphorylase
SCHRAMM VERN L1 citations50
US8884000B2Nov 11, 2014
Saporin-L1 inhibitors and uses thereof
SCHRAMM VERN L0 citations39
IND RES LTD
5 patentsUS7211653B2May 1, 2007
Inhibitors of nucleoside metabolism
IND RES LTD33 citations96
US6693193B1Feb 17, 2004
Process for preparing 2-pyrrolidinyl-1H-pyrrolo[3,2-d]pyrimidine inhibitors of nucleoside metabolism
IND RES LTD43 citations96
US7405297B2Jul 29, 2008
Process for preparing inhibitors of nucleoside metabolism
IND RES LTD24 citations92
US7553839B2Jun 30, 2009
5h-pyrrolo[3,2-D] pyrimidine inhibitors of nucleoside phosphorylases and nucleosidases
IND RES LTD31 citations91
US8383636B2Feb 26, 2013
Acyclic amine inhibitors of 5-methytioadenosine phosphorylase and nucleosidase
IND RES LTD4 citations57
EVANS GARY BRIAN
3 patentsUS8283345B2Oct 9, 2012
Azetidine analogues of nucleosidase and phosphorylase inhibitors
EVANS GARY BRIAN7 citations82
US8173662B2May 8, 2012
Fused pyrimidines as inhibitors of nucleoside phosphorylases and nucleosidases
EVANS GARY BRIAN12 citations81
US9493465B2Nov 15, 2016
3-hydroxypyrrolidine inhibitors of 5′-methylthioadenosine phosphorylase and nucleosidase
EVANS GARY BRIAN3 citations71
ALBERT EINSTEIN COLLEGE MEDICINE INC
3 patentsUS9522159B2Dec 20, 2016
Treatment and prevention of P. aeruginosa infections using coformycin analogs
ALBERT EINSTEIN COLLEGE MEDICINE INC3 citations67
US11186575B2Nov 30, 2021
Treatment of helicobacter pylori infections
ALBERT EINSTEIN COLLEGE MEDICINE INC0 citations56
US10118928B2Nov 6, 2018
Treatment of H. pylori infections using MTAN inhibitors
ALBERT EINSTEIN COLLEGE MEDICINE INC1 citations49